Investigating the efficacy of add-on acceptance and commitment therapy in the inpatient setting for depression and sleep disorders - a randomized controlled trial

Not Applicable

Recruiting

• Conditions: F33.0; F32.0; F32.1; F32.2; F33.1; F33.2; Mild depressive episode; Moderate depressive episode; Severe depressive episode without psychotic symptoms; Recurrent depressive disorder, current episode mild

• Registration Number: DRKS00032242
• Lead Sponsor: Klinikum Christophsbad - Christophsbad Akademie für Psychotherapie (C-AP) Forschungssektion für Angewandte Psychotherapie und Psychiatrie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-07-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

German fluent in spoken and written language

Exclusion Criteria

Reduction of intelligence according to clinical impression
Acute suicidality
Acute danger to others
Acute self-harm
Acute psychotic symptoms
Bipolar disorders (current or past episodes)
Schizophrenic disorders (current or past)
Presence of a dependency disorder
Biological therapy procedures: Electroconvulsive therapy (ECT) and esketamine treatment (Spravato)
Presence of hypersomnia
Suspected or presence of obstructive sleep apnea syndrome

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Depressive Symptomatology (Self-Assessment) (BDI-II)<br>Depressive Symptomatology (Observer Rating) (GRID-HAMD)<br>Subjective sleep problems (RIS)<br><br>3 measurement time points: T1 (baseline: 1 week before intervention), T2 (post measurement: 1 week after completion of intervention), T3 (follow-up measurement: 3 months after completion of intervention).

Secondary Outcome Measures

Name	Time	Method
Psychological flexibility (FAH-II)<br>Acceptance of sleep problems (SPAQ)<br>Subjective quality of life (WHOQOL-BREF)<br><br>3 measurement time points: T1 (baseline: 1 week before intervention), T2 (post measurement: 1 week after completion of intervention), T3 (follow-up measurement: 3 months after completion of intervention).